|
⚲
|
| Gentel Biosciences Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001392432 |
| Sale | 2008-11-21 ($3.0 M Offered, $2.7 M Sold) |
| Fund | |
| Phone | 6084412904 |
| Address | 5500 Nobel Drive Madison, 53711 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Chris Kendrickparker | |
| Larry Liozzo | |
| Alex Vodenlich | |
| Kenneth Johnson | |
| Robert de Bruin | |
| Tore Rasmussen | |
| Randy Durnell | |
| Lloyd Smith |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Brookside Mezzanine Fund III, L.P.
✚
|
0.0 | |
|
Brookwood Program Management, LLC
✚
|
0.0 | |
|
Brookwood Warwick Investors, LLC
✚
|
0.0 | |
|
Schuler Henri George
✚
|
0.0 | |
|
Schultz Jonathan B.
✚
|
0.0 | |
|
SCM SF 3509 LLC
✚
|
0.0 | |
|
Bullard John W
✚
|
0.0 | |
|
SCOR Inestment Partners UK Ltd
✚
|
0.0 | |
|
Scott James K
✚
|
0.0 | |
|
Bluewatch Happy a Series of CGF2021 LLC
✚
|
0.0 |